Longevity.Technology (@LongevityTech)· LongevityTech·· 4 小时前评分8
Zealand与Generate合作开发代谢病多特异性蛋白
Zealand Pharma and Generate Biomedicines will design multispecific proteins for metabolic disease, in a deal with nearly $1.2b in milesto...
导读
Zealand Pharma与Generate Biomedicines将设计用于代谢疾病的多特异性蛋白，交易里程碑金额近12亿美元。 https://vist.ly/5pmu2 #longevity #ZealandPharma #GenerateBiomedicines #metabolicdisease #biotech
来源：Longevity.Technology (@LongevityTech) · x.com